Bing Wei
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Biochemistry top 10%
- Sulfur Compounds in Biology
Papers in
-
- RNA modifications and cancer 11
- Circular RNAs in diseases 4
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 3
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Cancer Genomics and Diagnostics 5
- Co-authors
- Lei Zhan (5 shared papers)Jie Ma (8 shared papers)Yongjun Guo (7 shared papers)Lin Shi (2 shared papers)Jianguang Qi (2 shared papers)Pengfei Ren (2 shared papers)Xiuying Tang (2 shared papers)Jianqiang Feng (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Scientific Reports (1 paper)Frontiers in Immunology (1 paper)Journal of Cellular Physiology (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ChinaNetherlandsAustralia
In The Last Decade
Bing Wei
29 papers receiving 615 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 283
- Biochemistry 74
- Molecular Biology 408
- Endocrine and Autonomic Systems 30
- Pathology and Forensic Medicine 55
Countries citing papers authored by Bing Wei
This map shows the geographic impact of Bing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Wei more than expected).
Fields of papers citing papers by Bing Wei
This network shows the impact of papers produced by Bing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Wei. The network helps show where Bing Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 75 | |
| 2 | 2018 | 71 | |
| 3 | 2014 | 69 | |
| 4 | 2019 | 48 | |
| 5 | 2020 | 47 | |
| 6 | 2013 | 43 | |
| 7 | 2021 | 34 | |
| 8 | 2018 | 27 | |
| 9 | 2021 | 25 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 21 | |
| 12 | HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway. | 2018 | 19 |
| 13 | 2023 | 17 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2018 | 14 | |
| 17 | 2019 | 12 | |
| 18 | 2018 | 8 | |
| 19 | [Effects of high pulmonary blood flow on pulmonary vascular structure and the gene expression of cystathionine-gamma-lyase]. | 2003 | 6 |
| 20 | 2022 | 5 |
About Bing Wei
Bing Wei is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 33 papers that have together received 622 indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer Genomics and Diagnostics (5 papers), Circular RNAs in diseases (4 papers), Epigenetics and DNA Methylation (3 papers), BRCA gene mutations in cancer (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (283 citations), Biochemistry (74 citations), Molecular Biology (408 citations), Endocrine and Autonomic Systems (30 citations) and Pathology and Forensic Medicine (55 citations). Bing Wei has collaborated with scholars based in China, Netherlands and Australia. Frequent co-authors include Lei Zhan, Jie Ma, Yongjun Guo, Lin Shi, Jianguang Qi, Pengfei Ren, Xiuying Tang, Jianqiang Feng, Junbao Du and Ningning Yang. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Frontiers in Immunology, Journal of Cellular Physiology and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.